The financials
IQVIA by the numbers
IQVIA (IQV) reported revenue of $4.15B in Q1 2026 (quarter ended March 31, 2026), up 8.4% from the same quarter a year earlier. That came with a gross margin of 33% and net income of $274M (6.6% of revenue). For the full year FY2025, revenue was $16.3B (+5.9% year on year) and net income $1.36B. Its largest segment in 2026-Q2 was Research And Development Solutions at $1.14B, 56% of the disclosed total, just ahead of Commercial Solutions at 44%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $4.15B | $3.83B | +8.4% |
| Gross profit | $1.35B | $1.30B | +4.4% |
| Operating income | $514M | $496M | +3.6% |
| Net income | $274M | $249M | +10% |
| Diluted EPS | $1.61 | $1.40 | +15% |
| Operating | Revenue | Share |
|---|---|---|
| Research And Development Solutions | $1.14B | 56% |
| Commercial Solutions | $895M | 44% |
Business Segments
Revenue split by operating segment, from SEC XBRL filings.
Latest period: Q2 2026Total $2.04B (+2.8%)
Commercial Solutions grew +8.5% year on yearResearch And Development Solutions +3.1% year on year
Segment Latestquarter on quarteryear on year
- Research And Development Solutions$1.14B$1.14BQoQ +1.4%year on year +3.1%+1.4%+3.1%
- Commercial Solutions$895.0M$895.0MQoQ +4.6%year on year +8.5%+4.6%+8.5%
- Contract Sales And Medical Solutions--QoQ -year on year ---
- Technology And Analytics Solutions--QoQ -year on year ---
Diagnostics & Research
Ranks #11 of 29 by Smart Score